The news comes just days after Major League Baseball began its pandemic-shortened season.

ELVIS, it seems, has entered the operating room. 

New research out of Japan could help at-risk patients receive the care they need as soon as possible.

The device is roughly one-third the size of a AAA battery.

Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.

The devices offer numerous new features, including an improved battery, MRI compatibility and Bluetooth connectivity.

COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.